Eckman Law Group
Methods and compositions for treating malignant tumors associated with KRAS mutation
This invention provides methods and compositions for preventing, treating or ameliorating one or more symptoms of a malignant tumor associated with KRAS mutation in a mammal in need thereof, by identifying a tumor cell in the mammal, the tumor cell comprising at least one of: (i) a mutation of the KRAS gene, and (ii) an aberrant expression level of KRAS protein; and administering to the mammal a therapeutically effective amount of a composition comprising one or more RNAi molecules that are active in reducing expression of GST-π.
Nitto Denko Corporation
H C C C C C C C A C C C C C A A G A C C C C
H05K C12N C12N C12N C12N C12Q C12N C12N A61K C12N C12N C12N C12N C07F A61K A61B G01N A61P C07D C12N C12N C12N
inventional inventional additional inventional additional inventional additional additional inventional inventional additional additional additional inventional additional inventional inventional inventional inventional additional additional additional
Bharat Wenbin Li Roger Jihua Kenjirou
Majeti Ying Wang Adami Liu Minomi